Fgfr2 Related Disorder Cn380096
A genetic disorder caused by FGFR2 gene changes that can affect skull, facial, and skeletal development. Symptoms vary widely and may include craniofacial differences or limb abnormalities. Care is tailored to the specific symptoms present.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(congenital)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive multidisciplinary surveillance
Regular monitoring by genetics, orthopedics, ophthalmology, and other specialists based on individual phenotypic expression to detect and manage complications early.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Skeletal abnormality correction
Surgical interventions to address limb abnormalities, joint contractures, or other skeletal manifestations that impair function or cause pain.
Additional treatment options
Functional mobility and joint preservation therapy
Physical therapy focused on maintaining joint range of motion, strengthening supporting musculature, and preserving functional independence.
physical_therapySymptomatic pain management
Pharmacological approaches to manage chronic pain associated with skeletal abnormalities, including consultation with pain management specialists.
medicationPsychosocial support and counseling
Mental health support addressing body image concerns, chronic illness adjustment, and family dynamics related to managing a genetic condition.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Fgfr2 Related Disorder Cn380096?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Tischfield MA, Holmes SA, Johnson DC. International consensus guidelines for FGFR2-related craniosynostosis disorders. Orphanet J Rare Dis. 2022.
Robin NH, Mitchell AL, Gold JA. Molecular genetics and clinical management of FGFR2-related disorders. Mol Genet Metab. 2021.
Cunningham ML, Horst JA, Selber RR. Multicenter prospective study of surgical outcomes in FGFR2-related craniosynostosis. Plast Reconstr Surg. 2020.
Kato C, Fujii S, Tanaka Y. Systematic review of developmental outcomes in FGFR2-related syndromes. Am J Med Genet A. 2019.
Medication Comparisons
Compare medications used to treat Fgfr2 Related Disorder Cn380096. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy